Vertex Pharmaceuticals VRTX Earnings Call Transcripts

NASDAQ VRTX
$540.00 +10.31 (+1.95%)
At close: Oct 29, 2026 · 4:00 PM EDT
26 earnings calls on file for Vertex Pharmaceuticals, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Vertex Pharmaceuticals Q2 2026 Earnings Call

Aug 3, 2026 8,909 words · 39 min read
  • Dr. Reshma KewalramaniChief Executive Officer and President
  • Charles WagnerChief Operating Officer and Chief Financial Officer
  • Duncan J. McKechnieChief Commercial Officer
  • Susie LisaSenior Vice President of Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Vertex Pharmaceuticals Earnings Call Transcripts

Calls26
LatestAug 3, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 26 Vertex Pharmaceuticals transcripts Register to get access to Vertex Pharmaceuticals’s earnings call transcripts.